Internal Medicine, Nephrology · Huntington Park, CA
NPI
1386618304
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2677 Zoe Ave Ste 205
Huntington Park, CA, 90255
Phone (323) 589-6681
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$706K
6,285 prescriptions
Company payments, 2025
$549
From 12 companies
Medicare prescription drug claims, 2024
In 2024, the drug Pierre A Espenan prescribed most often to Medicare patients was Pravastatin Sodium, with 280 prescriptions and refills. In total Pierre A Espenan wrote 6,285 Medicare prescriptions that cost $706K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Pravastatin Sodium Generic | 280 | 602 | 70 | $2,159 |
| Metformin Hcl Generic | 237 | 549 | 65 | $2,021 |
| Benazepril Hcl Generic | 175 | 374 | 43 | $1,099 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 147 | 168 | 31 | $4,568 |
| Gabapentin Generic | 146 | 230 | 42 | $1,757 |
| Rosuvastatin Calcium Generic | 139 | 302 | 34 | $980 |
| Celecoxib Generic | 138 | 186 | 31 | $8,796 |
| Diclofenac Sodium Generic | 122 | 136 | 32 | $53K |
| Lubiprostone Generic | 119 | 191 | 24 | $29K |
| Icosapent Ethyl Generic | 99 | 175 | 23 | $27K |
| Duloxetine Hcl Generic | 87 | 127 | 15 | $2,248 |
| Famotidine Generic | 86 | 200 | 30 | $448 |
| Lisinopril Generic | 86 | 174 | 20 | $462 |
| Glipizide Generic | 84 | 204 | 28 | $896 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 83 | 96 | 15 | $22K |
Brand drugs: 944 claims; generic drugs: 5,280 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pierre A Espenan $549 ($549 in general payments such as food, travel and fees) from 12 companies. The largest payer was Sanofi-Aventis U.S. LLC with $137.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 5 | $137 |
| Amgen Inc. AMGN | 5 | $106 |
| Novo Nordisk Inc NVO | 4 | $89.38 |
| Pfizer Inc. PFE | 2 | $40.67 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.31 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $24.56 |
| Lilly USA, LLC LLY | 1 | $23.83 |
| Calliditas Therapeutics US Inc. | 1 | $23.47 |
| Xeris Pharmaceuticals, Inc. | 1 | $20.13 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $19.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.